한국 노인의 대사증후군 예측인자로서 혈중 Non HDL 콜레스테롤과 중성지방/HDL 콜레스테롤 비의 의의
Significance of Non HDL-cholesterol and Triglyceride to HDL-cholesterol Ratio as Predictors forMetabolic Syndrome among Korean Elderly
1
조회
0
다운로드
9
인용
0
참고문헌
키워드
초록
한국 노인을 대상으로 대사증후군 예측인자로서 혈중 Non HDL-콜레스테롤과 중성지방/HDL-콜레스테롤 비율의 임상적용 가능성을 평가하고자 하였다. 2015년 1월부터 2017년 12월까지 경기지역 종합병원의 건강검진센터를 내원하여 건강검진을 실시한 65세 이상 노인을 1,543명을 대상으로 하였다. 대사증후군은 American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI)기준에 따라 진단하였다. 복부비만은 World Health Organization (WHO) West Pacific Region에서 제시하는 아시아-태평양인의 기준을 적용하였다. Non HDL-콜레스테롤은 총콜레스테롤과 HDL-콜레스테롤의 차이로 계산하였다. 대사증후군 예측력은 Non HDL-콜레스테롤보다 중성지방/HDL-콜레스테롤 비율이 높게 나타났다. 관련요인을 보정한 후 중성지방/HDL-콜레스테롤 비율은 1사분위수보다 4사분위수의 대사증후군 발병 위험이 높았다. 또한 대사증후군 발병을 예측하는 중성지방/HDL-콜레스테롤 비율의 적정 기준값은 2.8이었다. 중성지방/HDL-콜레스테롤 비율은 대사증후군 위험을 평가하는 간단하고 실용적인 지표가 될 수 있겠다.
Abstract
We evaluated the possible clinical application of Non HDL-cholesterol and triglyceride to HDL-cholesterol ratio as a metabolic syndrome predictor for the elderly in Korea. 1,543 elderly persons aged 65 years or older who visited the health examination center of Gyeonggi Regional General Hospital from January 2015 to December 2017 and had a health checkup were enrolled in this study. Metabolic syndrome was diagnosed based on the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI) standards. Abdominal obesity was assessed by the Asia-Pacific standards presented at the World Health Organization (WHO) West Pacific Region. Non-HDL-cholesterol was calculated as the difference between total cholesterol and HDL- cholesterol. The metabolic syndrome predictive power was higher for triglyceride to HDL- cholesterol ratio than for Non HDL-cholesterol. After correcting for related factors, triglyceride to HDL-cholesterol ratio was higher in the 4th quartile, which had a higher risk of developing metabolic syndrome, than in the 1st quartile. The optimal cutoff value for the triglyceride to HDL-cholesterol ratio that predicts the onset of metabolic syndrome was 2.8. triglyceride to HDL-cholesterol ratio can be a simple and practical indicator of the risk of metabolic syndrome.
참고문헌 (34)
- Reaven GM, "Role of insulin resistance in human disease (syndrome X): an expanded definition", Annu Rev Med, 44, pp.121~131 (1993)[DOI]
- Park HS, "Prevalence of the metabolic syndrome among Korean adults according to the criteria of the International Diabetes Federation", Diabetes Care, 29, pp.933~934 (2006)[DOI]
- 임주원, "한국 노인에서 비만, 복부비만과 대사증후군의 유병률", Korean Journal of Family Medicine, 32(2), pp.128~134 (2011), 대한가정의학회
- Guize L, "Metabolic syndrome: prevalence, risk factors and mortality in a French population of 62,000 subjects", Bull Acad Natl Med, 190, pp.685~697 (2006)
- Miccoli R, "Prevalence of the metabolic syndrome among Italian adults according to ATP III definition", Nutr Metab Cardiovasc Dis, 15, pp.250~254 (2005)[DOI]
- Kawamoto R, "Non-HDL cholesterol as a predictor of carotid atherosclerosis in the elderly", J Atheroscler Thromb, 12, pp.143~148 (2005)[DOI]
- Cui Y, "Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality", Arch Intern Med, 161, pp.1413~1419 (2001)[DOI]
- Lu W, "Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study", Diabetes Care, 26, pp.16~23 (2003)[DOI]
- Keys A, "HDL serum cholesterol and 24-year mortality of men in Finland", Int J Epidemiol, 13, pp.428~435 (1984)[DOI]
- Menotti A, "Multivariate prediction of coronary deaths in a 10 year follow-up of an Italian occupational male cohort", Acta Cardiol, 47, pp.311~320 (1992)
- 이기호, "한국 여성의 대사증후군 이환에 대한 위험인자로서 혈중 Non-HDL 콜레스테롤 수치의 의의", Journal of Obesity & Metabolic Syndrome, 16(3), pp.102~110 (2007), 대한비만학회
- Salazar MR, "Relation among the plasma triglyceride", high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women, 2012, pp.109, 1749~1753
- Salazar MR, "Use of the plasma triglyceride", high-density lipoprotein cholesterol ratio to identify cardiovascular disease in hypertensive subjects, 2014, pp.8, 724~731
- Jeppesen J, "High triglycerides", low high-density lipoprotein cholesterol, ischemic electrocardiogram changes, and risk of ischemic heart disease, 2003, pp.145, 103~108
- Burchfiel CM, "Combined effects of HDL cholesterol, triglyceride, and total cholesterol concentrations on 18-year risk of atherosclerotic disease", Circulation, 92, pp.1430~1436 (1995)[DOI]
- Grundy SM, "Diagnosis and management of the metabolic syndrome: an American Heart Association", National Heart, Lung, and Blood Institute Scientific Statement, 2005, pp.112, 2735~2752
- World Health Organization, "The Asia-Pacific Perspective: redefining obesity and its treatment", pp.19~20 (2000)
- Seung Won Lee, "Thirty-Year Trends in Mortality from Cerebrovascular Diseases in Korea", Korean Circulation Journal, 46(4), pp.507~514 (2016), 대한심장학회
- Tsay YC, "Ages at onset of 5 cardiometabolic diseases adjusting for nonsusceptibility: implications for the pathogenesis of metabolic syndrome", Am J Epidemiol, 184, pp.366~377 (2016)[DOI]
- Wilson PW, "Prediction of coronary heart disease using risk factor categories", Circulation, 97, pp.1837~1847 (1998)[DOI]
- Baigent C, "Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials", Lancet, 376, pp.1670~1681 (2010)[DOI]
- Preiss D, "Biochemistry laboratories should routinely report non-HDL-cholesterol", Ann Clin Biochem, 52, pp.629~631 (2015)[DOI]
- Khan SH, "Status of non-HDL-cholesterol and LDL-cholesterol among subjects with and without metabolic syndrome", J Pak Med Assoc, 68, pp.554~558 (2018)
- Di Angelantonio E, "Major lipids, apolipoproteins, and risk of vascular disease", JAMA, 302, pp.1993~2000 (2009)[DOI]
- Ginsberg HN, "Regulation of plasma triglycerides in insulin resistance and diabetes", Arch Med Res, 36, pp.232~240 (2005)[DOI]
- Marotta T, "Triglyceride-to-HDL-cholesterol ratio and metabolic syndrome as contributors to cardiovascular risk in overweight patients", Obesity (Silver Spring), 18, pp.1608~1613 (2010)[DOI]
- McLaughlin T, "Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?", Am J Cardiol, 96, pp.399~404 (2005)[DOI]
- Kannel WB, "Usefulness of the triglyceride-high-density lipoprotein versus the cholesterol-high-density lipoprotein ratio for predicting insulin resistance and cardiometabolic risk (from the Framingham Offspring Cohort)", Am J Cardiol, 101, pp.497~501 (2008)[DOI]
- Kim-Dorner SJ, "Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance?", Metabolism, 59, pp.299~304 (2010)[DOI]
- Salazar MR, "Identification of cardiometabolic risk: visceral adiposity index versus triglyceride", HDL cholesterol ratio, 2014, pp.127, 152~157
- 오지영, "Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome", Yonsei Medical Journal, 57(6), pp.1404~1411 (2016), 연세대학교의과대학[DOI]
- Murguia-Romero M, "Plasma triglyceride", HDL-cholesterol ratio, insulin resistance, and cardiometabolic risk in young adults, 2013, pp.54, 2795~2799
- Eckel RH, "Alterations in lipoprotein lipase in insulin resistance", Int J Obes Relat Metab Disord, 19(Suppl 1), pp.S16~S21 (1995)
- Grundy SM, "Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome", Am J Cardiol, 81, pp.18~25 (1998)